Latest Cellular Medicine Development News

Page 1 of 1

Mesoblast Secures US$125M Credit Line, Slashes Debt Costs and Boosts Flexibility

Mesoblast has refinanced its senior debt with a new US$125 million, five-year credit facility that lowers borrowing costs and preserves key assets, positioning the company for strategic growth.

Ada Torres

30 Dec 2025

Browse the archive

Full archive

Aug 2026 July 2026 June 2026 May 2026 Apr 2026 Mar 2026 Feb 2026 Jan 2026